Selected research
Market Structure
Global Biotechnology Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biotechnology Contract Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biotechnology Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biotechnology Contract Manufacturing include Lonza, Thermo Fisher Scientific, Inc., Catalent, Inc., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Holding Corporation, AbbVie, Inc. and Eurofins Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Biotechnology Contract Manufacturing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biotechnology Contract Manufacturing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biotechnology Contract Manufacturing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biotechnology Contract Manufacturing market size, projected growth trends, production technologies, key applications, and end-use industries.
Biotechnology Contract Manufacturing Segment by Company
Lonza
Thermo Fisher Scientific, Inc.
Catalent, Inc.
Samsung Biologics
WuXi Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Holding Corporation
AbbVie, Inc.
Eurofins Scientific
AGC, Inc.
Merck KgaA
Biotechnology Contract Manufacturing Segment by Type
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
Biotechnology Contract Manufacturing Segment by Application
Monoclonal Antibodies
Cell Therapy & Gene Therapy
Antibody-Drug Conjugates (ADCs)
Vaccines
Therapeutic Peptides & Proteins
Others
Biotechnology Contract Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biotechnology Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biotechnology Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biotechnology Contract Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biotechnology Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biotechnology Contract Manufacturing industry.
Chapter 3: Detailed analysis of Biotechnology Contract Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biotechnology Contract Manufacturingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biologic Drug Substance Manufacturing
- Biologic Drug Product Manufacturing
Applications
- Monoclonal Antibodies
- Cell Therapy & Gene Therapy
- Antibody-Drug Conjugates (ADCs)
- Vaccines
- Therapeutic Peptides & Proteins
- Others
Companies covered
- Lonza
- Thermo Fisher Scientific, Inc.
- Catalent, Inc.
- Samsung Biologics
- WuXi Biologics
- Boehringer Ingelheim International GmbH
- FUJIFILM Holding Corporation
- AbbVie, Inc.
- Eurofins Scientific
- AGC, Inc.
- Merck KgaA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biotechnology Contract Manufacturing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Biologic Drug Substance Manufacturing
- 1.2.3 Biologic Drug Product Manufacturing
- 1.3 Market Analysis by Application
- 1.3.1 Global Biotechnology Contract Manufacturing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Monoclonal Antibodies
- 1.3.3 Cell Therapy & Gene Therapy
- 1.3.4 Antibody-Drug Conjugates (ADCs)
- 1.3.5 Vaccines
- 1.3.6 Therapeutic Peptides & Proteins
- 1.3.7 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Biotechnology Contract Manufacturing Growth Trends by Region
- 1.5.1 Global Biotechnology Contract Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biotechnology Contract Manufacturing Market Size by Region (2021-2026)
- 1.5.3 Biotechnology Contract Manufacturing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biotechnology Contract Manufacturing Market Dynamics
- 2.1 Biotechnology Contract Manufacturing Industry Trends
- 2.2 Biotechnology Contract Manufacturing Industry Drivers
- 2.3 Biotechnology Contract Manufacturing Industry Opportunities and Challenges
- 2.4 Biotechnology Contract Manufacturing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biotechnology Contract Manufacturing Revenue by Company (2021-2026)
- 3.2 Global Biotechnology Contract Manufacturing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biotechnology Contract Manufacturing Key Company Head office and Area Served
- 3.4 Global Biotechnology Contract Manufacturing Company, Product Type & Application
- 3.5 Global Biotechnology Contract Manufacturing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biotechnology Contract Manufacturing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biotechnology Contract Manufacturing Players Market Share by Revenue in 2025
- 3.6.3 2025 Biotechnology Contract Manufacturing Tier 1, Tier 2, and Tier 3
4 Biotechnology Contract Manufacturing Market by Type
- 4.1 Global Biotechnology Contract Manufacturing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biotechnology Contract Manufacturing Market Size by Type (2021-2032)
- 4.3 Global Biotechnology Contract Manufacturing Market Size Share by Type (2021-2032)
5 Biotechnology Contract Manufacturing Market by Application
- 5.1 Global Biotechnology Contract Manufacturing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biotechnology Contract Manufacturing Market Size by Application (2021-2032)
- 5.3 Global Biotechnology Contract Manufacturing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Lonza
- 6.1.1 Lonza Company Information
- 6.1.2 Lonza Business Overview
- 6.1.3 Lonza Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Lonza Biotechnology Contract Manufacturing Product Portfolio
- 6.1.5 Lonza Recent Developments
- 6.2 Thermo Fisher Scientific, Inc.
- 6.2.1 Thermo Fisher Scientific, Inc. Company Information
- 6.2.2 Thermo Fisher Scientific, Inc. Business Overview
- 6.2.3 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 6.2.5 Thermo Fisher Scientific, Inc. Recent Developments
- 6.3 Catalent, Inc.
- 6.3.1 Catalent, Inc. Company Information
- 6.3.2 Catalent, Inc. Business Overview
- 6.3.3 Catalent, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Catalent, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 6.3.5 Catalent, Inc. Recent Developments
- 6.4 Samsung Biologics
- 6.4.1 Samsung Biologics Company Information
- 6.4.2 Samsung Biologics Business Overview
- 6.4.3 Samsung Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Samsung Biologics Biotechnology Contract Manufacturing Product Portfolio
- 6.4.5 Samsung Biologics Recent Developments
- 6.5 WuXi Biologics
- 6.5.1 WuXi Biologics Company Information
- 6.5.2 WuXi Biologics Business Overview
- 6.5.3 WuXi Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 WuXi Biologics Biotechnology Contract Manufacturing Product Portfolio
- 6.5.5 WuXi Biologics Recent Developments
- 6.6 Boehringer Ingelheim International GmbH
- 6.6.1 Boehringer Ingelheim International GmbH Company Information
- 6.6.2 Boehringer Ingelheim International GmbH Business Overview
- 6.6.3 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Portfolio
- 6.6.5 Boehringer Ingelheim International GmbH Recent Developments
- 6.7 FUJIFILM Holding Corporation
- 6.7.1 FUJIFILM Holding Corporation Company Information
- 6.7.2 FUJIFILM Holding Corporation Business Overview
- 6.7.3 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Portfolio
- 6.7.5 FUJIFILM Holding Corporation Recent Developments
- 6.8 AbbVie, Inc.
- 6.8.1 AbbVie, Inc. Company Information
- 6.8.2 AbbVie, Inc. Business Overview
- 6.8.3 AbbVie, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 AbbVie, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 6.8.5 AbbVie, Inc. Recent Developments
- 6.9 Eurofins Scientific
- 6.9.1 Eurofins Scientific Company Information
- 6.9.2 Eurofins Scientific Business Overview
- 6.9.3 Eurofins Scientific Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Eurofins Scientific Biotechnology Contract Manufacturing Product Portfolio
- 6.9.5 Eurofins Scientific Recent Developments
- 6.10 AGC, Inc.
- 6.10.1 AGC, Inc. Company Information
- 6.10.2 AGC, Inc. Business Overview
- 6.10.3 AGC, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 AGC, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 6.10.5 AGC, Inc. Recent Developments
- 6.11 Merck KgaA
- 6.11.1 Merck KgaA Company Information
- 6.11.2 Merck KgaA Business Overview
- 6.11.3 Merck KgaA Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Merck KgaA Biotechnology Contract Manufacturing Product Portfolio
- 6.11.5 Merck KgaA Recent Developments
7 North America
- 7.1 North America Biotechnology Contract Manufacturing Market Size (2021-2032)
- 7.2 North America Biotechnology Contract Manufacturing Market Size by Type
- 7.2.1 North America Biotechnology Contract Manufacturing Market Size by Type (2021-2026)
- 7.2.2 North America Biotechnology Contract Manufacturing Market Size by Type (2027-2032)
- 7.2.3 North America Biotechnology Contract Manufacturing Market Share by Type (2021-2032)
- 7.3 North America Biotechnology Contract Manufacturing Market Size by Application
- 7.3.1 North America Biotechnology Contract Manufacturing Market Size by Application (2021-2026)
- 7.3.2 North America Biotechnology Contract Manufacturing Market Size by Application (2027-2032)
- 7.3.3 North America Biotechnology Contract Manufacturing Market Share by Application (2021-2032)
- 7.4 North America Biotechnology Contract Manufacturing Market Size by Country
- 7.4.1 North America Biotechnology Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 7.4.3 North America Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 7.4.4 North America Biotechnology Contract Manufacturing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biotechnology Contract Manufacturing Market Size (2021-2032)
- 8.2 Europe Biotechnology Contract Manufacturing Market Size by Type
- 8.2.1 Europe Biotechnology Contract Manufacturing Market Size by Type (2021-2026)
- 8.2.2 Europe Biotechnology Contract Manufacturing Market Size by Type (2027-2032)
- 8.2.3 Europe Biotechnology Contract Manufacturing Market Share by Type (2021-2032)
- 8.3 Europe Biotechnology Contract Manufacturing Market Size by Application
- 8.3.1 Europe Biotechnology Contract Manufacturing Market Size by Application (2021-2026)
- 8.3.2 Europe Biotechnology Contract Manufacturing Market Size by Application (2027-2032)
- 8.3.3 Europe Biotechnology Contract Manufacturing Market Share by Application (2021-2032)
- 8.4 Europe Biotechnology Contract Manufacturing Market Size by Country
- 8.4.1 Europe Biotechnology Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 8.4.3 Europe Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 8.4.4 Europe Biotechnology Contract Manufacturing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biotechnology Contract Manufacturing Market Size (2021-2032)
- 9.2 China Biotechnology Contract Manufacturing Market Size by Type
- 9.2.1 China Biotechnology Contract Manufacturing Market Size by Type (2021-2026)
- 9.2.2 China Biotechnology Contract Manufacturing Market Size by Type (2027-2032)
- 9.2.3 China Biotechnology Contract Manufacturing Market Share by Type (2021-2032)
- 9.3 China Biotechnology Contract Manufacturing Market Size by Application
- 9.3.1 China Biotechnology Contract Manufacturing Market Size by Application (2021-2026)
- 9.3.2 China Biotechnology Contract Manufacturing Market Size by Application (2027-2032)
- 9.3.3 China Biotechnology Contract Manufacturing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biotechnology Contract Manufacturing Market Size (2021-2032)
- 10.2 Asia Biotechnology Contract Manufacturing Market Size by Type
- 10.2.1 Asia Biotechnology Contract Manufacturing Market Size by Type (2021-2026)
- 10.2.2 Asia Biotechnology Contract Manufacturing Market Size by Type (2027-2032)
- 10.2.3 Asia Biotechnology Contract Manufacturing Market Share by Type (2021-2032)
- 10.3 Asia Biotechnology Contract Manufacturing Market Size by Application
- 10.3.1 Asia Biotechnology Contract Manufacturing Market Size by Application (2021-2026)
- 10.3.2 Asia Biotechnology Contract Manufacturing Market Size by Application (2027-2032)
- 10.3.3 Asia Biotechnology Contract Manufacturing Market Share by Application (2021-2032)
- 10.4 Asia Biotechnology Contract Manufacturing Market Size by Country
- 10.4.1 Asia Biotechnology Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 10.4.3 Asia Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 10.4.4 Asia Biotechnology Contract Manufacturing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Type
- 11.2.1 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Application
- 11.3.1 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Country
- 11.4.1 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biotechnology Contract Manufacturing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst